Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03028532Phase 1Completed
Phase 1, open-label, single-arm trial of clomiphene in secondary hypogonadism (HH) and male infertility. Primary endpoint: Detection window for clomiphene parent compound and metabolites at Day 72. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03028532.